Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | REGN5093-M114 |
Synonyms | |
Therapy Description |
REGN5093-M114 is an antibody-drug conjugate (ADC) comprised of a biparatopic MET antibody linked to a maytansinoid payload, which potentially inhibits tumor growth (Cancer Res 2022;82(12_Suppl):Abstract nr LB515A). |